Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
about
Thromboangiitis obliterans (Buerger's disease)Pharmacological treatment for Buerger's diseasePharmacological treatment for Buerger's diseaseThromboangiitis obliterans: current perspectives and future directionsBuerger's disease: providing integrated careIloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungsConditions presenting with symptoms of peripheral arterial diseaseThromboangiitis obliterans.Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practicesTreatment of thromboangiitis obliterans (Buerger's disease) with bosentan.Thromboangiitis obliterans. An update on Buerger's disease.Inhibitors of platelet signal transduction as anti-aggregatory drugs.Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteersSuccessful treatment of ergotism with Iloprost--a case report.Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case reportTreatment of Buerger's disease with electrical spinal cord stimulation--review of three cases.Buerger's Disease (Thromboangiitis Obliterans)- Management by Ilizarov's Technique of Horizontal Distraction. A Retrospective Study of 60 Cases.Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost.Gene therapy for vascular diseases.The Wound Healing Effects of Iloprost in Patients with Buerger's Disease: Claudication and Prevention of Major AmputationsThe prostacyclin analog, treprostinil sodium, provides symptom relief in severe Buerger's disease--a case report and review of literature.Gene therapy to restore prostacyclin presence to injured endotheliumThromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategy.Buerger's disease and cigarette smoking in Bangladesh.Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.Critical limb ischemia in a young man: saddle embolism or unusual presentation of thromboangiitis obliterans?Improvement in Blood Supply After "Heparin-Dextran" Therapy in Patients of Buerger's Disease with Critical Limb Ischemia.Efficacy of a novel method of intravenous infusion of the prostaglandin analogue iloprost for the treatment of lower-limb critical ischemia: An open-label, nonrandomized study in two cohorts.Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital.The role of autoimmunity in thromboangiitis obliterans (Buerger's disease).Nonatherosclerotic PAD: Approach to Exertional Pain in the Lower Extremities.Pathogenesis and Management of Buerger's Disease.Extreme distal bypass to improve wound healing in Buerger's disease.Successful intravenous regional sympathetic blockade (Bier's Block) with guanethidine and lidocaine in a patient with advanced Buerger's Disease (thromboangiitis obliterans)--a case report.Use of duplex ultrasonography in the treatment of thromboangiitis obliterans with iloprost.Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model.Digital artery occlusion secondary to plastic shopping bag traumaComparison Between Alprostadil and Iloprost in Intravenous Treatment of Patients With Chronic Peripheral Arterial Disease.Successful sequential drug eluting balloon angioplasty to chronic total occluded popliteal artery in a patient with thromboangitis obliterans by PCR.
P2860
Q21203052-406143EE-3322-45B6-8196-7D12B29DC398Q24186035-F10EDE72-F7D6-4C16-AA80-FEC154F7078AQ24186181-DBE9837D-0358-455C-AAC5-B09147DE0E8BQ24604058-A1C9C35B-0AEA-486C-8258-66C5474AF40DQ28072543-C678C145-813B-4416-B4B0-8F2A667F82D7Q28218337-31201E0D-06DE-463C-BD18-B45C796A40D2Q30301251-FB2402B9-9269-42FD-959E-6413A6092578Q33893309-8BB8AC84-19F8-490D-B42F-3C0FF61244B9Q33989390-72564D99-DA6D-49C2-8C01-4AD044165C31Q34158601-74CED7D0-E184-4598-96CF-D852EDC7CC7FQ34188275-CB55F609-1EA1-444E-A49D-884FFFF51E4CQ34232030-83EF350B-1D8D-45AD-A5C3-7D4066A930D3Q34403838-728E3479-4714-44FF-BCF0-E67C49A726F6Q34472309-26F98267-5CCA-4D75-8B1E-619B30EC124FQ34532454-A3ED3084-D59A-4399-ABBF-2DB808FC4F0EQ34652081-C3B46000-E00A-4FD1-B0CC-2ED8F3D802C0Q34796964-4D43D8C2-2FDC-4A74-B005-649AAB20BD4AQ35203476-DFA803FC-05F8-408A-B613-558B08732216Q35652189-9B0D8949-0B78-4B18-AAE9-B35119A869D1Q36022330-574FF29A-801A-45BE-A7A7-4A1AD50D280AQ36380897-DAC338D8-F814-45E1-89E5-9934569B4680Q36647148-C056B6B2-0DFF-4258-AF89-F9EE1D1F5C77Q36757085-784F802A-EECD-4F74-9B55-069C68EF4B76Q36813673-24D49D15-A6D0-433F-8B8A-177DE33BD4F7Q37206152-D99C6F3F-B8D5-4AA2-869A-A57E9FFDA64DQ37395283-4A1D7283-D58A-471C-93B9-CDB27A277CB4Q37400453-52D347AD-010A-4D9D-8E56-C74ED2C5246FQ37510919-76F0026A-9A42-4F07-B257-F6D1D8DE7BC0Q37661074-D8A22E8B-9EEA-420A-B0BF-A6908AF4C3D4Q37670132-51499A74-3EAE-43D8-86C4-0C9C7A0A5AE1Q38091139-F85CFB87-92D9-4153-87B5-5F46448759E2Q38545044-CED7EF37-7F23-4F14-B0E9-581478FCD8C7Q38564798-EACC2FB4-A409-4036-A232-33A8702EA370Q39210461-6E97B8B8-5FCC-4463-9F30-319F1160DAF0Q39363710-F7332575-37E8-4EDC-B238-F11D2E612D45Q39683680-A9327B06-44A6-4C15-8D8A-49FDBC21F985Q39746690-768F84B8-A5C6-4199-A864-9B99610B28F1Q39829330-4B02D873-A997-4D37-927D-224126CB81B1Q41033325-0D324933-132F-4F0E-A3B2-26AE4785B7D4Q41869103-4DFA15C7-21E6-47E5-9847-915CB9195F6C
P2860
Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Trial of iloprost versus aspir ...... tis obliterans. The TAO Study.
@ast
Trial of iloprost versus aspir ...... tis obliterans. The TAO Study.
@en
type
label
Trial of iloprost versus aspir ...... tis obliterans. The TAO Study.
@ast
Trial of iloprost versus aspir ...... tis obliterans. The TAO Study.
@en
prefLabel
Trial of iloprost versus aspir ...... tis obliterans. The TAO Study.
@ast
Trial of iloprost versus aspir ...... tis obliterans. The TAO Study.
@en
P1433
P1476
Trial of iloprost versus aspir ...... tis obliterans. The TAO Study.
@en
P2093
J N Fiessinger
P304
P356
10.1016/0140-6736(90)90346-7
P407
P577
1990-03-01T00:00:00Z